Androgen receptor function and targeted therapeutics across breast cancer subtypes

Despite significant progress in breast cancer (BC) therapy, it is globally the most commonly diagnosed cancer and leads to the death of over 650,000 women annually. Androgen receptor (AR) is emerging as a potential new therapeutic target in BC. While the role of AR is well established in prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolyvas, Emily A., Caldas, Carlos, Kelly, Kathleen, Ahmad, Saif S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664788/
https://www.ncbi.nlm.nih.gov/pubmed/36376977
http://dx.doi.org/10.1186/s13058-022-01574-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664788/
https://www.ncbi.nlm.nih.gov/pubmed/36376977
http://dx.doi.org/10.1186/s13058-022-01574-4

Ejemplares similares